Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney DiseaseDick de Zeeuw, Glenn M. Chertow, Angie Goldsberry et al.|New England Journal of Medicine|2013Cited by 990
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS InhibitorsMatthew R. Weir, Bertram Pitt, George L. Bakris et al.|New England Journal of Medicine|2014Cited by 658
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J.L. Heerspink, Rey Isidto, Bergur V. Stefánsson et al.|Nephrology Dialysis Transplantation|2019Cited by 216